BR0315754A - Duloxetina, uso da mesma, e, composição farmacêutica - Google Patents

Duloxetina, uso da mesma, e, composição farmacêutica

Info

Publication number
BR0315754A
BR0315754A BR0315754-7A BR0315754A BR0315754A BR 0315754 A BR0315754 A BR 0315754A BR 0315754 A BR0315754 A BR 0315754A BR 0315754 A BR0315754 A BR 0315754A
Authority
BR
Brazil
Prior art keywords
duloxetine
pharmaceutical composition
duloxetin
administration
medical
Prior art date
Application number
BR0315754-7A
Other languages
English (en)
Inventor
Michael J Detke
David Joel Goldstein
Smriti Iyengar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR0315754A publication Critical patent/BR0315754A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

"DULOXETINA, USO DA MESMA, E, COMPOSIçãO FARMACEUTICA". A presente invenção pertence aos campos das quimicas médica e farmacêutica, e fornece um novo método de tratamento de distúrbios gastrintestinais mediante a administração de duloxetina.
BR0315754-7A 2002-11-19 2003-11-18 Duloxetina, uso da mesma, e, composição farmacêutica BR0315754A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42751402P 2002-11-19 2002-11-19
PCT/US2003/035051 WO2004045606A1 (en) 2002-11-19 2003-11-18 Treatment of gastrointestinal disorders with duloxetine

Publications (1)

Publication Number Publication Date
BR0315754A true BR0315754A (pt) 2005-09-06

Family

ID=32326550

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315754-7A BR0315754A (pt) 2002-11-19 2003-11-18 Duloxetina, uso da mesma, e, composição farmacêutica

Country Status (9)

Country Link
US (1) US20050272805A1 (pt)
EP (1) EP1565182A1 (pt)
JP (1) JP2006508978A (pt)
CN (1) CN1713906A (pt)
AU (1) AU2003287499A1 (pt)
BR (1) BR0315754A (pt)
CA (1) CA2506673A1 (pt)
MX (1) MXPA05004935A (pt)
WO (1) WO2004045606A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8153824B2 (en) * 2005-06-22 2012-04-10 The Wockhardt Company Antidepressant oral liquid compositions
AU2009206204B2 (en) * 2008-01-25 2015-03-19 Alphapharm Pty Ltd Delayed release pharmaceutical composition of duloxetine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
CA2344057C (en) * 1998-09-15 2008-11-18 Eli Lilly And Company Treatment of persistent pain
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
WO2002062324A2 (en) * 2001-02-05 2002-08-15 Michael Albert Kamm A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
EP1499309A4 (en) * 2002-04-24 2008-05-28 Cypress Bioscience Inc PREVENTION AND TREATMENT OF FUNCTIONAL SOMATIC DISEASES, INCLUDING STRESS-BASED DISEASES

Also Published As

Publication number Publication date
AU2003287499A1 (en) 2004-06-15
JP2006508978A (ja) 2006-03-16
CN1713906A (zh) 2005-12-28
WO2004045606A1 (en) 2004-06-03
CA2506673A1 (en) 2004-06-03
US20050272805A1 (en) 2005-12-08
EP1565182A1 (en) 2005-08-24
MXPA05004935A (es) 2005-07-22

Similar Documents

Publication Publication Date Title
SE0001899D0 (sv) New compounds
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
BR0310092A (pt) Combinação de compostos orgânicos
BR0208150A (pt) Antagonistas de mch e sua aplicação no tratamento da obesidade
BR0110573A (pt) Composto, composição farmacêutica que compreende esse composto, processo para a preparação de uma composição farmacêutica, utilização do composto e processo para o tratamento profilático ou terapêutico e para a preparação do composto
DE60144064D1 (de) Sulfone, die die aktivität von gamma-secretase modulieren
BR0111457A (pt) Derivados de acilfeniluréia, processos para a sua preparação e sua aplicação como medicamentos
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
CY1108808T1 (el) Ενωσεις μοτιλιδης
BR0206568A (pt) Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BR0012696A (pt) Composição oftálmica
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
SE0102147D0 (sv) New methods
RS8504A (en) Novel cyclohexil sulphones
HK1058515A1 (en) Use of pamoic acid for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates.
IT1318667B1 (it) Medicamento antinfiammatorio.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]